The K650E gain-of-function mutation in the tyrosine kinase domain of FGF receptor 3 (FGFR3) causes Thanatophoric Dysplasia type II, a neonatal lethal congenital dwarfism syndrome, and when acquired somatically, it contributes to carcinogenesis. In this report, we determine the crystal structure of the FGFR3 kinase domain harboring this pathogenic mutation and show that the mutation introduces a network of intramolecular hydrogen bonds to stabilize the active-state conformation. In the crystal, the mutant FGFR3 kinases are caught in the act of transphosphorylation on a kinase insert autophosphorylation site, emphasizing the fact that the K650E mutation circumvents the requirement for A-loop tyrosine phosphorylation in kinase activation. Analysis of this trans-phosphorylation complex sheds light onto the determinants of tyrosine transphosphorylation specificity. We propose that the targeted inhibition of this pathogenic FGFR3 kinase may be achievable by small molecule kinase inhibitors that selectively bind the active-state conformation of FGFR3 kinase.
INTRODUCTION
Fibroblast growth factor receptor (FGFR) tyrosine kinases mediate the pleiotropic effects of FGFs in human biology and pathology. Gain-of-function mutations in the tyrosine kinase domains of FGFRs underlie a wide array of human developmental disorders and malignancies (Beenken and Mohammadi, 2009; Goriely et al., 2009; Webster and Donoghue, 1997b; Wilkie, 2005) . FGFs act in concert with either heparin sulfate cofactors or Klotho coreceptors to bind and dimerize the ecto-domains of FGFRs, bringing the cytoplasmic tyrosine kinase domains into proper proximity and orientation, which allows trans-phosphorylation on activation loop (A-loop) tyrosines to occur (Goetz and Mohammadi, 2013) . This event triggers kinase activation and causes additional transphosphorylation reactions on tyrosines in the kinase C-terminal tail and juxtamembrane (JM) region to create specific recruitment sites for substrates, thereby increasing the proximity of substrate to the kinase and facilitating substrate phosphorylation (Bae et al., 2009; Chen et al., 2008; Goetz and Mohammadi, 2013; Mohammadi et al., 1996a) .
Crystallographic and nuclear magnetic resonance (NMR) studies of FGFR kinase domains in the unphosphorylated and A-loop phosphorylated states, as well as constitutively active FGFR kinases that harbor pathogenic gain-of-function mutations (Bae et al., 2009; Chen et al., 2007 Chen et al., , 2013 Mohammadi et al., 1996a) , show that the FGFR kinase is principally regulated at the protein dynamics level by an autoinhibitory network of hydrogen bonds in the kinase hinge/interlobe region (termed "molecular brake"), which restrains the kinase from transitioning into the active state (Chen et al., 2007 (Chen et al., , 2013 . Upon A-loop tyrosine phosphorylation, the phosphate moiety of the phosphorylated A-loop tyrosine makes intramolecular hydrogen bonds with an RTK-invariant arginine at the N-terminal end of the A-loop, helping to restructure the A-loop into the active conformation. The change in the conformation of the A-loop is then allosterically communicated to the kinase hinge region, causing disengagement of the molecular brake, and hence maximal kinase activation (Chen et al., 2007 (Chen et al., , 2013 .
In FGFRs, the kinase hinge and A-loop are the two hotspots for pathogenic gain-of-function mutations (Bellus et al., 1995 (Bellus et al., , 2000 Kan et al., 2002; Wilkie, 2005) . Previously, we explored the mechanisms for FGFR activation by the pathogenic mutations at the kinase hinge, which led to the discovery of the autoinhibitory molecular brake (Chen et al., 2007) . The K650E mutation in the A-loop of FGFR3 kinase is one of the most activating, and hence pathogenic mutations (Bellus et al., 2000; Naski et al., 1996; Webster et al., 1996; Webster and Donoghue, 1997a) . When occurring in the germline, the K650E mutation causes Thanatophoric Dysplasia type II, a neonatal lethal dwarfism syndrome (Tavormina et al., 1995; Wilcox et al., 1998) .If acquired somatically, it contributes to the progression of multiple myeloma, bladder cancer and benign skin tumors (Cappellen et al., 1999; Chesi et al., 1997; Logié et al., 2005) .
There is a wealth of literature on the molecular mechanisms by which the hyperactive K650E mutant reduces proliferation of chondrocytes, causing them to prematurely enter into hypertrophic differentiation in the developing cartilage tissue. The effects of the K650E mutation on FGFR activation, maturation/trafficking, and downstream signaling pathways have been extensively studied (Foldynova-Trantirkova et al., 2012; Guo et al., 2008) . Webster and colleagues showed that the A-loop tyrosines are dispensable for the constitutive activity of the K650E FGFR3 mutant, implying that K650E mutation activates the kinase in an A-loop phosphorylation-independent fashion (Webster et al., 1996) . Hence, it was proposed that this pathogenic mutation mimics the action of A-loop tyrosine phosphorylation to activate the kinase (Webster et al., 1996) . The molecular mechanism by which this mutation imparts constitutive activation upon FGFR3 kinase is perplexing, however, because in accordance with the crystal structures of A-loop phosphorylated FGFR1 and FGFR2 kinases, the corresponding lysine residues, namely, K656 and K659, make intramolecular hydrogen bonds with the phosphate moiety of the phosphorylated Aloop tyrosine and residues in the A-loop that actually help supporting the active A-loop conformation (Bae et al., 2010; Chen et al., 2007) . Lievens and Liboi showed that the K650E mutation affects receptor maturation and that the constitutively active mutant accumulates as a mannose-rich and phosphorylated form in the endoplasmic reticulum, where it signals through activating STAT1 and Src (Lievens and Liboi, 2003) . Using a neurite outgrowth differentiation assay in PC12 cells as readout, Nowroozi and colleagues suggested that activation of STAT1 and 3 may not be required for the K650E mutant to induce hypertrophic differentiation of the growth plate (Nowroozi et al., 2005) . Agazie and colleagues showed that the K650E mutant requires SHP2 to induce oncogenic transformation of cells (Agazie et al., 2003) .
The importance of elucidating the molecular mechanism by which the K650E mutation confers gain-of-function on FGFR3 kinase is 2-fold; first, it may provide new insight into the physiological mechanisms of FGFR kinase regulation, and second, it may facilitate the rational design of small molecule inhibitors that can specifically silence the hyperactivity of this pathogenic FGFR3 mutant. Here, we report the crystal structure of FGFR3 kinase that harbors the K650E mutation. The structure shows that the mutation functionally mimics the action of A-loop phosphorylation in activating the kinase by introducing a network of hydrogen bonds that stabilize the active-state conformation of the A-loop. Moreover, the structure provides a snapshot of two FGFR kinase molecules engaged in the act of transphosphorylation on the kinase insert tyrosine. Comparison of this trans-phosphorylation complex with a previously reported kinase trans-phosphorylation complex involving the Cterminal tail tyrosine (Chen et al., 2008) provides valuable insights into the molecular mechanism that controls trans-phosphorylation specificity. Based on our structural data, targeted inhibition of this pathogenic FGFR3 kinase can be achieved by small molecule kinase inhibitors that selectively bind the active-state conformation of FGFR3 kinase.
RESULTS
To elucidate the molecular basis by which the pathogenic K650E mutation imparts constitutive activation upon FGFR3 kinase in human diseases, we solved the crystal structure of the FGFR3K K650E mutant in complex with AMP-PCP, a nonhydrolyzable ATP analog, at 2.35Å resolution ( Figure 1A ). Data collection and structure refinement statistics are given in Table 1 . The refined model consists of residues L459 to T755, one AMP-PCP molecule, two Mg 2+ ions, and 128 water molecules. FGFR3K K650E exhibits the canonical two-lobe architecture of protein kinases with the smaller N-lobe comprising a twisted fivestranded sheet and the helix C, and the larger C-lobe consists mainly of helices ( Figure  1 ). The ATP analog AMP-PCP is tucked snugly in the ATP-binding cleft between the two lobes, where it makes numerous hydrogen bonds and hydrophobic contacts with residues in both lobes as well as in the kinase hinge region (Figure 1 ). The entire A-loop, bracketed between 635 DFG and LPV 658 motifs, is ordered, including the two tyrosine residues (Y647 and Y648), the phosphorylation of which is necessary for kinase activation. Most of the loop between the D and E helices, better known as the kinase insert region, is ordered as well ( Figure 1A ). The ordering of this highly flexible loop is attributable to the fact that the autophosphorylation site Y577 from this loop inserts into the catalytic pocket of a neighboring kinase in the crystal, thereby forming an enzyme-substrate transphosphorylation complex.
The K650E Mutation Confers Gain-of-Function by Stabilizing the Active Conformation of the Kinase A-Loop
Superimposition of the FGFR3K K650E structure onto the structures of unphosphorylated (low activity state) and A-loop phosphorylated (active state) FGFR1 (Bae et al., 2009; Mohammadi et al., 1996a) and FGFR2 (Chen et al., 2007 (Chen et al., , 2008 kinases unambiguously shows that FGFR3K K650E is in the active-state conformation ( Figure 1B ; Figure S1 available online). The A-loop of FGFR3K K650E superimposes onto that of phosphorylated FGFR1 and FGFR2 kinases with root-mean-square deviations (rmsd) of 0.81 and 1.2Å, respectively, and features the strands 10 and 12 that are characteristics of the activated kinases ( Figure 1 ). A network of intramolecular hydrogen bonds introduced by the K650E mutation facilitates and stabilizes the active-state conformation of the A-loop in the FGFR3K K650E structure ( Figure 1B) . Specifically, the carboxylate group of E650 makes five hydrogen bonds: two with R616 in the catalytic loop, one each with the backbone amides of T651 and T652, and one with Y648 within the A-loop (Figures 1B and S2) . The latter hydrogen bond helps position the side chain of Y648 into a nearly identical location as that of the corresponding phosphorylated tyrosine residue in the A-loop phosphorylated wild-type (WT) FGFR1 and FGFR2 kinases ( Figure S1 ). The hydroxyl group of Y648 in FGFR3K K650E makes an intramolecular hydrogen bond with R640 at the N-terminal end of the A-loop, which is reminiscent of the hydrogen bonds that the phosphate moiety of the phosphorylated A-loop tyrosine makes with the invariant A-loop arginine ( Figures 1B and  S2 ). This hydrogen bond likely also contributes to the active-state conformation of the Aloop.
As in the crystal structures of A-loop phosphorylated, activated FGFR1 and FGFR2 kinases (Bae et al., 2009; Chen et al., 2007) , the autoinhibitory molecular brake at the kinase hinge/ interlobe region of FGFR3K K650E is disengaged, providing further evidence that the mutation drives the kinase into the active state ( Figure S3 ). The active-state conformation of FGFR3K K650E is also apparent by the formation of a catalytically important salt bridge between the invariant E525 in the C helix and K508 in the 3 strand of the kinase N-lobe ( Figure 1C ). This salt bridge primes K508 for hydrogen bonding with the and phosphate groups of AMP-PCP ( Figure 1C ). Analysis of crystal packing contacts provides additional strong evidence that the mutated FGFR3 kinase has adopted the active-state conformation. In the crystal, FGFR3K K650E molecules are trapped in the act of trans-phosphorylation, whereby one kinase molecule acts as the enzyme, while the other serves as the substrate, offering a phosphorylatable tyrosine residue from the kinase insert region (Y577) (Figure 2 ). The hydroxyl moiety Y577 of the substrate-acting kinase engages in two short-range hydrogen bonds with the catalytic base D617 of the enzyme-acting kinase and is about 5Å away from the -phosphate of the ATP analog AMP-PCP, indicating that Y577 from the substrate-acting kinase is poised for deprotonation and phosphorylation by the enzymeacting kinase (Figure 2 ). Given the fact that substrate binding is strictly dependent on kinase activation (Hubbard and Till, 2000) , this observation lends further support for the fact that the K650E mutation has forced the FGFR3 kinase into the active state. Taken together, these structural findings unambiguously demonstrate that the pathogenic K650E mutation confers gain-of-function by functionally mimicking the action of A-loop tyrosine phosphorylation in stabilizing the active-state conformation of the A-loop.
The K650E Mutation Activates FGFR3 Kinase Independent of A-Loop Tyrosine Phosphorylation
To functionally validate our structural finding that the K650E mutation circumvents the requirement for A-loop tyrosine phosphorylation for FGFR3 kinase activation, we next compared the kinase activity of FGFR3K K650E with that of FGFR3K K650E harboring Y647F or Y648F single mutations or the Y647F/Y648F double mutation in vitro ( Figures 3A-3E ). As expected, FGFR3K K650E exhibited greater activity than wild-type FGFR3K (FGFR3K WT ) at every time point examined, with the greatest difference (over 20-fold) seen at 20 s, the earliest measured time point ( Figure 3F ). The difference in activity between FGFR3K K650E and FGFR3K WT tapered off at later time points, however. This is expected, as A-loop tyrosine phosphorylation takes place over time, amplifying the catalytic activity of FGFR3K WT . The activity of the FGFR3K K650E mutants in which one or both A-loop tyrosine residues has been replaced with phenylalanine remains comparable to that of the parent FGFR3K K650E molecule ( Figure 3F ), corroborating that kinase activation by the K650E mutation occurs independent of A-loop tyrosine phosphorylation. Our data are consistent with the previously published data by Webster and colleagues showed that the Aloop tyrosines are dispensable for the constitutive activity of the K650E FGFR3 mutant, implying that K650E mutation activates the kinase in an A-loop phosphorylationindependent fashion (Webster et al., 1996) . Notably, unlike FGFR3K WT , the activity of FGFR3K K650E did not increase significantly over time ( Figure 3F ), further substantiating that the K650E mutation activates the kinase independent of A-loop tyrosine phosphorylation. Taken together, these biochemical data support the structural finding that the K650E mutation confers constitutive activation by essentially mimicking the action of A-loop tyrosine phosphorylation in stabilizing the active-state conformation of the kinase.
Structural Basis for Specificity of Tyrosine trans-Phosphorylation in FGFR3 Kinase
The crystal structure of FGFR3K K650E depicts, as already mentioned, a snapshot of a transphosphorylation reaction on the kinase insert tyrosine residue Y577. We previously reported the crystal structure of FGFR2 kinases caught in the act of trans-phosphorylation on the FGFR-invariant C-terminal tail tyrosine (Chen et al., 2008) . Comparison of the two kinase trans-phosphorylation complexes provides important insights into the molecular determinants of specificity of kinase tyrosine trans-phosphorylation. Similar to the Cterminal tail tyrosine trans-phosphorylation complex, the kinase insert tyrosine transphosphorylation complex is also asymmetric, wherein the C-lobe of the substrate-acting kinase engages both the N-and C-lobe of the enzyme-acting kinase (Figure 2) . The enzymesubstrate interface can be roughly divided into a proximal and a distal site, with the former in the vicinity of the catalytic cleft of the enzyme-acting kinase and the latter remote from the catalytic cleft of the enzyme-acting kinase.
At the proximal interface, several contacts in the kinase insert tyrosine transphosphorylation complex ( Figure 4A ) diverge from those observed in the C-terminal tail tyrosine trans-phosphorylation complex ( Figure 4B ). Notably, in stark contrast to the Cterminal tail tyrosine trans-phosphorylation complex, where the P+1 pocket of the enzyme plays an important role in providing specificity at the proximal enzyme-substrate interface ( Figure 4B ), this pocket is not utilized in the kinase insert tyrosine trans-phosphorylation complex. Instead, proximal specificity in this complex is primarily achieved by R655 from the A-loop of the enzyme-acting kinase. The guanidinium moiety of R655 stacks against the phenyl ring of Y577 via a -cation interaction and also forms a hydrogen bond with the backbone carbonyl oxygen of P573 in the kinase insert of the substrate-acting kinase ( Figure  4A ).
At the distal interface, the contacts in the kinase insert tyrosine trans-phosphorylation complex are completely different from those observed in the C-terminal tail tyrosine transphosphorylation complex. The main specific contacts in the distal site of the kinase insert tyrosine trans-phosphorylation complex are two hydrogen bonds between R571 (from the Nterminal end of the kinase insert of the substrate-acting kinase) and the backbone carbonyl oxygen atom of D513 in the loop between 3 strand and C helix of the enzyme-acting kinase ( Figure 4A ). All of the remaining interactions at this distal contact site are of van der Waals nature with the most notable ones being the contacts between F483 from the nucleotide-binding loop of the enzyme-acting kinase and R571 of the substrate-acting kinase.
To functionally probe the observed mode of trans-phosphorylation specificity on the kinase insert tyrosine in the FGFR3K K650E crystal, we studied the impact of mutating R571 to alanine on phosphorylation of the kinase insert tyrosine Y577. Consistent with the structural data, the R571A mutation drastically impaired phosphorylation of the kinase insert tyrosine (Y577) but had only a minor effect on the phosphorylation of the C-terminal tail tyrosine (Y760) ( Figure 4D ). As expected based on our previous crystal structure of the C-terminal tail tyrosine trans-phosphorylation complex (Chen et al., 2008) , substitution of L761, which engages the P+1 pocket of the enzyme, with alanine caused a major decrease in the kinase C-terminal tail tyrosine phosphorylation but had little impact on phosphorylation of the kinase insert tyrosine ( Figure 4E ).
DISCUSSION
In this study we elucidated the molecular mechanism by which the pathogenic K650E mutation in FGFR3, which underlies a lethal skeletal dysplasia in humans, confers gain-offunction on FGFR3. Our data unambiguously demonstrate that the K650E mutation mimics the action of A-loop tyrosine phosphorylation to cause ligand-independent activation of FGFR3. It should be noted that enzymes, in general, and tyrosine kinases, in particular, are intrinsically dynamic protein moieties, and in fact the catalytic turnover rate of enzymes is strongly correlated with magnitude and timescales of internal motions that enzymes undergo (Eisenmesser et al., 2005; Villali and Kern, 2010) . Using X-ray crystallography and NMR spectroscopy, we have recently shown that FGFR kinases swing between an inhibited state, which is conformationally rigid and stable, and an active state, which is conformationally dynamic and hence inhomogeneous (Chen et al., 2013) . The unphosphorylated wild-type FGFR kinase can sample the active state albeit with low frequency and hence predominately populates the inhibited state. Pathogenic mutations, such as the K650E mutation, introduce intramolecular contacts that facilitate the ability of the kinase to adopt and remain longer in the active state, thereby increasing the population of kinase molecules in the active state (Chen et al., 2013) . In other words, the crystallographically fixed intramolecular hydrogen bonding contacts introduced by the mutation are dynamic in solution, and the FGFR3K K650E pathogenic kinase also oscillates between inhibited and active states with the equilibrium being skewed toward the active state.
Comparison of the kinase insert tyrosine trans-phosphorylation complex in the FGFR3K K650E crystal with the FGFR2 kinase C-terminal tail tyrosine trans-phosphorylation complex (Chen et al., 2008) shows that kinase trans-phosphorylation entails a great degree of sequence specificity and structural complementarities. It remains to be determined whether Y577 of FGFR3 is phosphorylated in living cells. However, the equivalent tyrosine in FGFR1, Y583, is a bona fide in vivo phosphorylation site (Mohammadi et al., 1996b) and is also a second major autophosphorylation site in vitro (Furdui et al., 2006) . Y577 is readily phosphorylated in vitro, both in the wild-type and in the K650E mutant FGFR3 kinases. Based on these observations, we surmise that Y577 undergoes phosphorylation in vivo as well. Future efforts should be directed toward elucidating the structural basis for transphosphorylation on the A-loop tyrosines, the earliest trans-phosphorylation event necessary for kinase activation. A full comprehension of the molecular details of FGFR transphosphorylation reactions will be essential to understanding FGFR signaling and devising novel strategies for targeted modulation of FGF signaling for therapeutic purposes.
EXPERIMENTAL PROCEDURES
Please refer to the Supplemental Experimental Procedures for full details.
Protein Expression and Purification
The human FGFR3 kinase domains FGFR3K , including their mutated forms, and the C-terminal tail peptide of FGFR2 kinase (FGFR2K 761-821 ) were all expressed using pET bacterial expression vectors with an N-terminal 6XHis-tag to aid in protein purification.
Crystallization and Structure Determination
Crystals of the FGFR3K K650E protein in complex with the ATP-analog (AMP-PCP) were grown by vapor diffusion at 20°C using crystallization buffer composed of 0.1 M HEPES (pH 7.5), 20% (w/v) PEG 4000, and 4% (v/v) (±)-1,3 Butanediol. Diffraction data were processed using the HKL2000 suite (Otwinowski and Minor, 1997) , and the structure was solved by the molecular replacement program AMoRe (Navaza, 1994) , using the crystal structure of FGFR2 kinase that harbors the K659N mutation (Protein Data Bank [PDB] ID code 2PVY) (Chen et al., 2007) as the search model. Model building was carried out using O (Jones et al., 1991) , and at later stages Coot (Emsley and Cowtan, 2004) was used, and refinement was completed using PHENIX (Adams et al., 2002) . 
Dissection of the

Analysis of the Specificity of Tyrosine trans-Phosphorylation
The trans-phosphorylation on kinase insert and C-terminal tail tyrosines in wild-type and mutated FGFR3 kinases (FGFR3K ) were analyzed by LTQ Orbitrap (Thermo Electron) liquid chromatography-tandem mass spectrometry.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. (B) A detailed view of the interface formed between the enzyme-acting and substrate-acting kinases. The interacting residues are shown as sticks and labeled in black for the enzymeacting kinase and in blue for the substrate-acting kinase. The kinase insert region is colored wheat, and the side chain of the Y577 residue is shown as yellow sticks and labeled in red. The hydrogen bonds are shown as black dashed lines. Atom coloring is as in Figure 1 . See also Figure S1 . (F) The percentage of at least one site phosphorylation on the substrate was quantitated using the peak intensity data generated by mass spectrometry. For the sake of accuracy, only the MS data of the early time points (20, 40, and 60 s), which are in the linear phase of the kinase assay, were processed and presented. (B) Based on the crystal structure of FGFR2 kinases trapped in the act of transphosphorylation on C-terminal tail tyrosine, the hydrophobic contacts between L761 of substrate and the P+1 pocket of the enzyme are critical for tyrosine trans-phosphorylation specificity on the C-terminal tail tyrosine Y760 in FGFR3. To highlight the hydrophobic contacts between the substrate and the enzyme at the P+1 pocket, the molecular surfaces of P+1 and P+3 residues (L761 and L763) of the substrate and residues in the P+1 pocket of the enzyme (L656, V700, and F704) are shown. Enzyme-acting kinases in both transphosphorylation complexes are colored green. Substrate-acting kinases are colored cyan and salmon in kinase insert and C-terminal tail tyrosine trans-phosphorylation complexes, respectively. (C-E) Analysis of autophosphorylation by mass spectrometry corroborates the importance of R571 and L761 in substrate recognition in the kinase insert and C-terminal tail tyrosine trans-phosphorylation. The R571A mutation diminishes trans-phosphorylation on the kinase insert tyrosine Y577 without a major impact on the C-terminal tail tyrosine phosphorylation (D). The L761A mutation (equivalent to L770A in FGFR2) impairs the transphosphorylation of the C-terminal tail tyrosine Y760 (E).
